Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen
|Organization:||University of Pittsburgh, PA, US|
|I.P. Brief:||The invention provides a method of activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor. |
|Keywords:||immunotherapy, anti-cancer agent, Finn|
|Primary Industry:||Health & Medical Devices|
Full IP Descriptions available on-site.